#stat6degrader — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #stat6degrader, aggregated by home.social.
-
Kymera reports positive KT-621 phase 1 Japanese study results
Kymera Therapeutics (NASDAQ:KYMR) reported positive findings from its Phase 1 clinical trial evaluating KT-621, a first-in-class oral small…
#EuropeSays #Japan #JP #asthma #atopicdermatitis #immunologypipeline #Japanese #JapaneseDermatologicalAssociation #KT-621 #KymeraTherapeutics #KYMR #Phase1clinicaldata #STAT6degrader #targetedproteindegradation
https://www.europesays.com/japan/39510/